Tumour angiogenesis regulation by the miR-200 family

Nature Communications

Volumn 4, Issue , 2013, Pages

  Pecot, Chad V ^a   Rupaimoole, Rajesha ^a   Yang, Da ^a   Akbani, Rehan ^a   Ivan, Cristina ^a   Lu, Chunhua ^a   Wu, Sherry ^a   Han, Hee Dong ^a   Shah, Maitri Y ^a   Rodriguez Aguayo, Cristian ^a   Bottsford Miller, Justin ^a   Liu, Yuexin ^a   Kim, Sang Bae ^a   Unruh, Anna ^a   Gonzalez Villasana, Vianey ^a   Huang, Li ^a   Zand, Behrouz ^a   Moreno Smith, Myrthala ^a   Mangala, Lingegowda S ^a   Taylor, Morgan ^a   Dalton, Heather J ^a   Sehgal, Vasudha ^a   Wen, Yunfei ^a   Kang, Yu ^a   Baggerly, Keith A ^a   Lee, Ju Seog ^a   Ram, Prahlad T ^a   Ravoori, Murali K ^a   Kundra, Vikas ^a   Zhang, Xinna ^a   Ali Fehmi, Rouba ^b   Gonzalez Angulo, Ana Maria ^a   Massion, Pierre P ^c   Calin, George A ^a   Lopez Berestein, Gabriel ^a   Zhang, Wei ^a   Sood, Anil K ^a   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; INTERLEUKIN 8; MICRORNA 200; ANGIOGENESIS INHIBITOR; MICRORNA; MIRN200 MICRORNA, HUMAN; NANOPARTICLE; OLIGONUCLEOTIDE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL LIKE BREAST CANCER; CANCER CELL; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; KIDNEY CANCER; LUNG CANCER; METASTASIS; MOUSE; MULTIGENE FAMILY; NONHUMAN; OVARY CANCER; BIOLOGICAL MODEL; BREAST NEOPLASMS; CELL MOTION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; PERICYTE; SECONDARY; TREATMENT OUTCOME; VASCULARIZATION; BREAST TUMOR; DRUG EFFECT; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY);

ANGIOGENESIS INHIBITORS; BREAST NEOPLASMS; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; INTERLEUKIN-8; LUNG NEOPLASMS; MICRORNAS; MODELS, BIOLOGICAL; NANOPARTICLES; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDES; PERICYTES; TREATMENT OUTCOME;

EID: 84887251722     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3427     Document Type: Article

References (41)

1. Korpal, M., Lee, E. S., Hu, G. & Kang, Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 283, 14910-14914 (2008).
2. Park, S. M., Gaur, A. B., Lengyel, E. & Peter, M. E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22, 894-907 (2008).
3. Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10, 593-601 (2008).
4. Korpal, M. et al. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat. Med. 17, 1101-1108 (2011).
5. Dykxhoorn, D. M. et al. miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One 4, e7181 (2009).
6. Hu, X. et al. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. Gynecol. Oncol. 114, 457-464 (2009).
7. Marchini, S. et al. Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections. Lancet Oncol. 12, 273-285 (2011).
8. Nam, E. J. et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin. Cancer. Res. 14, 2690-2695 (2008).
9. Feng, B., Wang, R., Song, H. Z. & Chen, L. B. MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3. Cancer 118, 3365-3376 (2012).
10. Patnaik, S. K., Kannisto, E., Knudsen, S. & Yendamuri, S. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res. 70, 36-45 (2010).
11. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70 (2012).
12. Gregory, P. A., Bracken, C. P., Bert, A. G. & Goodall, G. J. MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 7, 3112-3118 (2008).
13. Korpal, M. & Kang, Y. The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis. RNA Biol. 5, 115-119 (2008).
14. Komurov, K., White, M. A. & Ram, P. T. Use of data-biased random walks on graphs for the retrieval of context-specific networks from genomic data. PLoS Comput. Biol. 6, e1000889 (2010).
15. Merritt, W. M. et al. Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. J. Natl Cancer Inst. 100, 359-372 (2008).
16. Hanrahan, E. O. et al. Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and/or chemotherapy in patients with non-small-cell lung cancer. J. Clin. Oncol. 28, 193-201 (2010).
17. Tran, H. T. et al. Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials. Lancet Oncol. 13, 827-837 (2012).
18. Young, R. J. et al. Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide. Br. J. Cancer 106, 1153-1159 (2012).
19. Gyorffy, B. et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res. Treat. 123, 725-731 (2010).
20. Chan, Y. C., Khanna, S., Roy, S. & Sen, C. K. miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells. J. Biol. Chem. 286, 2047-2056 (2011).
21. Choi, Y. C., Yoon, S., Jeong, Y., Yoon, J. & Baek, K. Regulation of vascular endothelial growth factor signaling by miR-200b. Mol. Cells 32, 77-82 (2011).
22. Gibbons, D. L. et al. Contextual cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev. 23, 2140-2151 (2009).
23. Fasanaro, P. et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J. Biol. Chem. 283, 15878-15883 (2008).
24. Landen, C. N. et al. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res. 65, 6910-6918 (2005).
25. Lu, C. et al. Regulation of tumor angiogenesis by EZH2. Cancer Cell 18, 185-197 (2010).
26. Pecot, C. V., Calin, G. A., Coleman, R. L., Lopez-Berestein, G. & Sood, A. K. RNA interference in the clinic: challenges and future directions. Nat. Rev. Cancer 11, 59-67 (2011).
27. Han, H. D. et al. Targeted gene silencing using RGD-labeled chitosan nanoparticles. Clin. Cancer Res. 16, 3910-3922 (2010).
28. Cooke, V. G. et al. Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer Cell 21, 66-81 (2012).
29. Carmeliet, P. & Jain, R. K. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat. Rev. Drug Discov. 10, 417-427 (2011).
30. Iliopoulos, D. et al. Loss of miR-200 inhibition of Suz12 leads to polycombmediated repression required for the formation and maintenance of cancer stem cells. Mol. Cell 39, 761-772 (2010).
31. Shimono, Y. et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138, 592-603 (2009).
32. Cochrane, D. R., Howe, E. N., Spoelstra, N. S. & Richer, J. K. Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers. J. Oncol. 2010, 821717 (2010).
33. Adam, L. et al. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin. Cancer Res. 15, 5060-5072 (2009).
34. Ceppi, P. et al. Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non-Small Cell Lung Cancer. Mol. Cancer Res. 8, 1207-1216 (2010).
35. Schickel, R., Park, S. M., Murmann, A. E. & Peter, M. E. miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1. Mol. Cell 38, 908-915 (2010).
36. Acharyya, S. et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 150, 165-178 (2012).
37. Kim, M. Y. et al. Tumor self-seeding by circulating cancer cells. Cell 139, 1315-1326 (2009).
38. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl Cancer Inst. 82, 4-6 (1990).
39. van Beijnum, J. R., van der Linden, E. & Griffioen, A. W. Angiogenic profiling and comparison of immortalized endothelial cells for functional genomics. Exp. Cell. Res. 314, 264-272 (2008).
40. Onn, A. et al. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice. Clin. Cancer Res. 9, 5532-5539 (2003).
41. Thaker, P. H. et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat. Med. 12, 939-944 (2006).